Buscar resultados de ensayos clínicos
Paramyxoviridae Infections - 25 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Study to Evaluate the Safety of MEDI-534 Vaccine Against Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3) in Healthy Children Condición: Healthy Fecha: 2006-06-27 Intervenciones:
|
Withdrawn |
Nombre del estudio: DAS181 in Patients With Parainfluenza Condición: Parainfluenza Infection Fecha: 2011-09-24 Intervenciones:
|
Completed |
Nombre del estudio: Safety of and Immune Response to Recombinant Live-Attenuated Parainfluenza Type 1 Virus Vaccine Condición:
Fecha: 2008-03-05 Intervenciones:
|
Recruiting |
Nombre del estudio: A Study to Assess the Safety of Live Intranasal Sendai Virus Vaccine in Children and Toddlers Condición:
Fecha: 2005-09-12 Intervenciones: Biological: Sendai virus vaccine Enders strain; a live, unmodified intranasally administered Sendai viru |
Completed |
Nombre del estudio: Evaluating the Safety of and Immune Response to a Human Parainfluenza Virus Type 3 Ebola Virus Vaccine (HPIV3-EbovZ GP) in Healthy Adults Condición: Hemorrhagic Fever, Ebola Fecha: 2015-09-29 Intervenciones: Biological: HPIV3-EbovZ GP Vaccine Administered intranasally by a VaxINator device |
Completed |
Nombre del estudio: Safety, Efficacy and Pharmacokinetics of BTA-C585 in a RSV Viral Challenge Study Condición: Respiratory Syncytial Virus (RSV) Infection Fecha: 2016-03-21 Intervenciones:
|
Recruiting |
Nombre del estudio: Evaluating the Infectivity, Safety, and Immunogenicity of a Single Dose of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (D46/NS2/N/ΔM2-2-HindIII) in RSV-Seronegative Infants 6 to 24 Months of Age Condición: Respiratory Syncytial Virus Infections Fecha: 2017-03-23 Intervenciones:
|
Recruiting |
Nombre del estudio: Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (D46/NS2/N/ΔM2-2-HindIII) in RSV-Seronegative Infants and Children 6 to 24 Months of Age Condición: Respiratory Syncytial Virus Infections Fecha: 2017-03-28 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: A Study to Rank Different Dosages of Antigen of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3003891A), Based on Their Immune Response and Safety, When Administered to Healthy Adult Women Condición: Respiratory Syncytial Virus Infections Fecha: 2016-11-03 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: Evaluating the Infectivity, Safety, and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine in RSV-Seronegative Infants and Children 6 to 24 Months of Age Condición: Respiratory Syncytial Virus Infections Fecha: 2016-10-31 Intervenciones:
|